Advertisement

Topics

AACR 2018: Combination therapy strengthens T cells in melanoma pre-clinical study

09:19 EDT 17 Apr 2018 | ecancermedicalscience

A pre-clinical study of two drugs designed to boost T cell performance, has revealed the agents, when given in combination, may enhance the immune system’s ability to kill melanoma tumours deficient in the tumour suppressor gene PTEN. The study was led...

Original Article: AACR 2018: Combination therapy strengthens T cells in melanoma pre-clinical study

NEXT ARTICLE

More From BioPortfolio on "AACR 2018: Combination therapy strengthens T cells in melanoma pre-clinical study"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Skin cancers
There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma and malignant melanoma. Basal cell carcinoma Basal cell carcinoma, or BCC, is a cancer of the basal cells at the bottom of the epidermis. It’s very common ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...